To investigate the nasopharyngeal carriage and antimicrobial susceptibility of H. influenzae among children younger than 5 years old and to assess antibiotics usage patterns in the outpatient department of Beijing Children's Hospital from 2000 to 2004.

Materials and Methods

From 2000 to 2004, At least 100 strains of H. influenzae were isolated from the pediatric patients who were younger than 5 years and who presented with symptoms of acute upper respiratory tract infections during February to May in each of the study years. Antimicrobial susceptibilities were determined; and antibiotics usage was expressed as defined daily dose (DDD)/100 patient days.

Results

The overall nasopharyngeal carriage rate of H. influenzae is 26.3% (562/2,137) in children younger than 5 years old with acute upper respiratory tract infection. The percentage of ampicillin-resistant isolates ranges from 4.0% (4/100) to 14.3% (17/119) from 2000 to 2004. All the ampicillin-resistant isolates are β-lactamase producers. More than 80% of the isolates are susceptible to amoxicillin, cefaclor, and chloramphenicol; whereas, almost all (99–100%) of the isolates are sensitive to amoxicillin/clavulanic acid, ceftriaxone, and cefuroxime. For antibiotics utilization, macrolides are the predominantly used antibiotics, followed by cephalosporins and penicillins among pediatric patients in the outpatient department during the study period.

Conclusion

All amoxicillin-resistant isolates of H. influenzae are producing β-Lactamase; and the rates of amoxicillin-resistant isolates are increasing over time. Amoxicillin/clavulanic acid and cephalosporins are highly sensitive to H. influenzae isolated from Chinese pediatric patients. Macrolides are the most used antibiotics in the outpatient department during the study period. Pediatr Pulmonol. 2008; 43:457–462. © 2008 Wiley-Liss, Inc.

REFERENCES

1 Fluit AC, Schmitz FJ, Jones ME, Acar J, Gupta R, Verhoef J. Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY participants group. Int J Infect Dis 1999; 3: 153–156.
10.1016/S1201-9712(99)90037-1
CAS PubMed Google Scholar
2 Jacobs MR, Johnson CE. Macrolide resistance: an increasing concern for treatment failure in children. Pediatr Infect Dis 2003; 22: S131–S138.
10.1097/00006454-200308001-00004
PubMed Web of Science® Google Scholar
3 Yang Y, Shen X, Jiang Z, Liu X, Leng Z, Lu D, Rao J, Liu J, Chang L. Study on Haemophilus influenzae type b diseases in China: the past, present and future. Pediatr Infect Dis 1998; 17: S159–S165.
10.1097/00006454-199809001-00013
CAS PubMed Web of Science® Google Scholar
4 Wang YJ, Vuori-Holopainen E, Yang Y, Wang Y, Hu Y, Leboulleux D, Hedman K, Leinonen M, Peltola H. Relative frequency of haemophilus influenzae type b pneumonia in Chinese children as evidenced by serology. Pediatr Infect Dis 2002; 21: 271–277.
10.1097/00006454-200204000-00002
Web of Science® Google Scholar
5 Dagan R, Klugman KP, Craig WA, Baquero F. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother 2001; 47: 129–140.
10.1093/jac/47.2.129
CAS PubMed Web of Science® Google Scholar
6 Fogarty CM, Kohno S, Buchanan P, Aubier M, Baz M. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin. J Antimicrob Chemother 2003; 51: 947–955.
10.1093/jac/dkg153
CAS PubMed Web of Science® Google Scholar
7 Alpuche C, Garau J, Lim V. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens. Int J Antimicrob Agents 2007; 30: 135–138.
10.1016/j.ijantimicag.2007.07.035
CAS PubMed Web of Science® Google Scholar
8 O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972; 1: 283–288.
10.1128/AAC.1.4.283
PubMed Web of Science® Google Scholar
9 National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test. 6th ed NCCLS Document M2-A6. Villanova, PA: National Committee For Clinical Laboratory Standards. 2002.
Google Scholar
10 The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). Oslo, Norway: World Heath Organization Centre for Drug Statistic Methodology: 2005.
Google Scholar
11 Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in school children in Pittsburgh. N Engl J Med 2002; 346: 1200–1206.
10.1056/NEJMoa013169
PubMed Web of Science® Google Scholar
12 Lehmann D, Gratten M, Montgomery J. Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive pneumococci. Pediatr Infect Dis J 1997; 16: 297–305.
10.1097/00006454-199703000-00009
CAS PubMed Web of Science® Google Scholar
13 Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN. The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229–246.
10.1093/jac/dkg321
CAS PubMed Web of Science® Google Scholar
14 Blosser-Middleton R, Sahm DF, Thornsberry C, Jones ME, Hogan PA, Critchley IA, Karlowsky JA. Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000–2001. Clin Microbiol Infect 2003; 9: 431–436.
10.1046/j.1469-0691.2003.00543.x
CAS PubMed Web of Science® Google Scholar
15 Sanbongi Y, Suzuki T, Osaki Y, Senju N, Ida T, Ubukata K. Molecular evolution of beta-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob Agents Chemother 2006; 50: 2487–2492.
10.1128/AAC.01316-05
CAS PubMed Web of Science® Google Scholar
16 Karlowsky JA, Thornsberry C, Critchley IA, Jones ME, Evangelista AT, Noel GJ, Sahm DF. Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000–2001 and 2001–2002 TRUST studies in the United States. Antimicrob Agents Chemother 2003; 47: 1790–1797.
10.1128/AAC.47.6.1790-1797.2003
CAS PubMed Web of Science® Google Scholar
17 Jain A, Kumar P, Awasthi S. High ampicillin resistance in different biotypes and serotypes of Haemophilus influenzae colonizing the nasopharynx of healthy school-going Indian children. J Med Microbiol 2006; 55: 133–137.
10.1099/jmm.0.46249-0
CAS PubMed Web of Science® Google Scholar
18 Heilmann KP, Rice CL, Miller AL, Miller NJ, Beekmann SE, Pfaller MA, Richter SS, Doern GV. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob Agents Chemother 2005; 49: 2561–2564.
10.1128/AAC.49.6.2561-2564.2005
CAS PubMed Web of Science® Google Scholar
19 Zhanel GG, Palatnick L, Nichol KA, Low DE, Hoban DJ. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003; 47: 1875–1881.
10.1128/AAC.47.6.1875-1881.2003
CAS PubMed Web of Science® Google Scholar
20 Yang YH, Fu SG, Peng H, Shen AD, Yue SJ, Go YF, Yuan L, Jiang ZF. Abuse of antibiotics in China and its potential interference in determining the etiology of pediatric bacterial diseases. Pediatr Infect Dis 1993; 12: 986–988.
10.1097/00006454-199312000-00004
CAS PubMed Web of Science® Google Scholar
21 Scott JA, Mwarumba S, Ngetsa C, Njenga S, Lowe BS, Slack MP, Berkley JA, Mwangi I, Maitland K, English M, Marsh K. Progressive increase in antimicrobial resistance among invasive isolates of Haemophilus influenzae obtained from children admitted to a hospital in Kilifi, Kenya, from 1994 to 2002. Antimicrob Agents Chemother 2005; 49: 3021–3024.
10.1128/AAC.49.7.3021-3024.2005
CAS PubMed Google Scholar
22 Ronning M, Blix HS, Harbo BT, Strom H. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose—are drug utilisation data comparable? Eur J Clin Pharmacol 2000; 56: 723–727.
10.1007/s002280000200
CAS PubMed Web of Science® Google Scholar
23 Melander E, Ekdahl K, Jonsson G, Molstad S. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J 2000; 19: 1172–1177.
10.1097/00006454-200012000-00011
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume43, Issue5

May 2008

Pages 457-462

Antimicrobial susceptibility of Haemophilus influenzae strains and antibiotics usage patterns in pediatric outpatients: Results from a children's hospital in China (2000–2004)

Abstract

Objective

Materials and Methods

Results

Conclusion

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Antimicrobial susceptibility of Haemophilus influenzae strains and antibiotics usage patterns in pediatric outpatients: Results from a children's hospital in China (2000–2004)

Abstract

Objective

Materials and Methods

Results

Conclusion

REFERENCES

Citing Literature

References

Related

Information